Giant cell myocarditis with prolonged cardiac standstill after drug‐induced hypersensitivity syndrome: a case report

Abstract Giant cell myocarditis (GCM) is a rare but fatal disease that can lead to cardiac failure. Survival with a cardiac standstill requires mechanical circulatory support or a biventricular assist device (BiVAD) and prolonged survival is extremely rare. Drug‐induced hypersensitivity syndrome (DI...

Full description

Bibliographic Details
Main Authors: Ryohei Ono, Hiroki Kohno, Sae Kaminota, Kaoruko Aoki, Hirotoshi Kato, Togo Iwahana, Takanori Aihara, Masayuki Ota, Goro Matsumiya, Yoshio Kobayashi
Format: Article
Language:English
Published: Wiley 2024-04-01
Series:ESC Heart Failure
Subjects:
Online Access:https://doi.org/10.1002/ehf2.14678
_version_ 1797242804510916608
author Ryohei Ono
Hiroki Kohno
Sae Kaminota
Kaoruko Aoki
Hirotoshi Kato
Togo Iwahana
Takanori Aihara
Masayuki Ota
Goro Matsumiya
Yoshio Kobayashi
author_facet Ryohei Ono
Hiroki Kohno
Sae Kaminota
Kaoruko Aoki
Hirotoshi Kato
Togo Iwahana
Takanori Aihara
Masayuki Ota
Goro Matsumiya
Yoshio Kobayashi
author_sort Ryohei Ono
collection DOAJ
description Abstract Giant cell myocarditis (GCM) is a rare but fatal disease that can lead to cardiac failure. Survival with a cardiac standstill requires mechanical circulatory support or a biventricular assist device (BiVAD) and prolonged survival is extremely rare. Drug‐induced hypersensitivity syndrome (DIHS) is a severe cutaneous adverse reaction. Some cases of DIHS are reportedly associated with the onset of GCM. We present a case of a 28‐year‐old woman who developed GCM during steroid tapering after DIHS. She went into continuous cardiac standstill but survived for 74 days under BiVAD support. Our case is noteworthy because the histopathologic specimens obtained on three occasions contributed to the diagnosis of this particular condition over time. We also reviewed previous literature on concomitant cases of GCM and DIHS. We found that two are potentially associated and most cases of GCM occur within 3 months of DIHS during steroid tapering.
first_indexed 2024-04-24T18:45:02Z
format Article
id doaj.art-33ff91c739a045028ce842873e51c37e
institution Directory Open Access Journal
issn 2055-5822
language English
last_indexed 2024-04-24T18:45:02Z
publishDate 2024-04-01
publisher Wiley
record_format Article
series ESC Heart Failure
spelling doaj.art-33ff91c739a045028ce842873e51c37e2024-03-27T06:48:03ZengWileyESC Heart Failure2055-58222024-04-0111280581010.1002/ehf2.14678Giant cell myocarditis with prolonged cardiac standstill after drug‐induced hypersensitivity syndrome: a case reportRyohei Ono0Hiroki Kohno1Sae Kaminota2Kaoruko Aoki3Hirotoshi Kato4Togo Iwahana5Takanori Aihara6Masayuki Ota7Goro Matsumiya8Yoshio Kobayashi9Department of Cardiovascular Medicine Chiba University Graduate School of Medicine Chiba JapanDepartment of Cardiovascular Surgery Chiba University Graduate School of Medicine Chiba JapanChiba University School of Medicine Chiba JapanDepartment of Cardiovascular Medicine Chiba University Graduate School of Medicine Chiba JapanDepartment of Cardiovascular Medicine Chiba University Graduate School of Medicine Chiba JapanDepartment of Cardiovascular Medicine Chiba University Graduate School of Medicine Chiba JapanDepartment of Pathology Chiba University Hospital Chiba JapanDepartment of Diagnostic Pathology, Graduate School of Medicine Chiba University Chiba JapanDepartment of Cardiovascular Surgery Chiba University Graduate School of Medicine Chiba JapanDepartment of Cardiovascular Medicine Chiba University Graduate School of Medicine Chiba JapanAbstract Giant cell myocarditis (GCM) is a rare but fatal disease that can lead to cardiac failure. Survival with a cardiac standstill requires mechanical circulatory support or a biventricular assist device (BiVAD) and prolonged survival is extremely rare. Drug‐induced hypersensitivity syndrome (DIHS) is a severe cutaneous adverse reaction. Some cases of DIHS are reportedly associated with the onset of GCM. We present a case of a 28‐year‐old woman who developed GCM during steroid tapering after DIHS. She went into continuous cardiac standstill but survived for 74 days under BiVAD support. Our case is noteworthy because the histopathologic specimens obtained on three occasions contributed to the diagnosis of this particular condition over time. We also reviewed previous literature on concomitant cases of GCM and DIHS. We found that two are potentially associated and most cases of GCM occur within 3 months of DIHS during steroid tapering.https://doi.org/10.1002/ehf2.14678Biventricular assist deviceCardiac arrestCardiac standstillDrug‐induced hypersensitivity syndromeGiant cell myocarditisReview
spellingShingle Ryohei Ono
Hiroki Kohno
Sae Kaminota
Kaoruko Aoki
Hirotoshi Kato
Togo Iwahana
Takanori Aihara
Masayuki Ota
Goro Matsumiya
Yoshio Kobayashi
Giant cell myocarditis with prolonged cardiac standstill after drug‐induced hypersensitivity syndrome: a case report
ESC Heart Failure
Biventricular assist device
Cardiac arrest
Cardiac standstill
Drug‐induced hypersensitivity syndrome
Giant cell myocarditis
Review
title Giant cell myocarditis with prolonged cardiac standstill after drug‐induced hypersensitivity syndrome: a case report
title_full Giant cell myocarditis with prolonged cardiac standstill after drug‐induced hypersensitivity syndrome: a case report
title_fullStr Giant cell myocarditis with prolonged cardiac standstill after drug‐induced hypersensitivity syndrome: a case report
title_full_unstemmed Giant cell myocarditis with prolonged cardiac standstill after drug‐induced hypersensitivity syndrome: a case report
title_short Giant cell myocarditis with prolonged cardiac standstill after drug‐induced hypersensitivity syndrome: a case report
title_sort giant cell myocarditis with prolonged cardiac standstill after drug induced hypersensitivity syndrome a case report
topic Biventricular assist device
Cardiac arrest
Cardiac standstill
Drug‐induced hypersensitivity syndrome
Giant cell myocarditis
Review
url https://doi.org/10.1002/ehf2.14678
work_keys_str_mv AT ryoheiono giantcellmyocarditiswithprolongedcardiacstandstillafterdruginducedhypersensitivitysyndromeacasereport
AT hirokikohno giantcellmyocarditiswithprolongedcardiacstandstillafterdruginducedhypersensitivitysyndromeacasereport
AT saekaminota giantcellmyocarditiswithprolongedcardiacstandstillafterdruginducedhypersensitivitysyndromeacasereport
AT kaorukoaoki giantcellmyocarditiswithprolongedcardiacstandstillafterdruginducedhypersensitivitysyndromeacasereport
AT hirotoshikato giantcellmyocarditiswithprolongedcardiacstandstillafterdruginducedhypersensitivitysyndromeacasereport
AT togoiwahana giantcellmyocarditiswithprolongedcardiacstandstillafterdruginducedhypersensitivitysyndromeacasereport
AT takanoriaihara giantcellmyocarditiswithprolongedcardiacstandstillafterdruginducedhypersensitivitysyndromeacasereport
AT masayukiota giantcellmyocarditiswithprolongedcardiacstandstillafterdruginducedhypersensitivitysyndromeacasereport
AT goromatsumiya giantcellmyocarditiswithprolongedcardiacstandstillafterdruginducedhypersensitivitysyndromeacasereport
AT yoshiokobayashi giantcellmyocarditiswithprolongedcardiacstandstillafterdruginducedhypersensitivitysyndromeacasereport